Trip Hofer Archives - Mediformatica

How Redox is Future-Proofing Healthcare Data as Interoperability Standards Evolve – MedCity News

February 5, 2025February 5, 2025MedCity News

The push for healthcare initiatives including value-based care and AI requires robust data sharing and timely access to healthcare data. This is an area in which Redox is well-versed. Since its founding in 2014,…

HIStalk Interviews Trip Hofer, CEO, Redox – HIStalk

June 24, 2024June 25, 2024HIStalk

Trip Hofer, MBA is CEO of Redox.

Tell me about yourself and the company.
I joined the organization in November of last year. I’ve been in healthcare for approaching 25 years now, and…

Brightside Health Raises Strategic Series C, Welcomes Trip Hofer to Board of Directors | Healthcare IT Today

April 29, 2024April 29, 2024Healthcare IT Today

With Over $100M in Total Funding, the Telemental Health Company is Poised for its Next Phase of Growth
Telemental health company Brightside Health today announced a strategic Series C raise led by S32, as well as the…

Diverging trajectories of trust in healthcare and on-line information seeking: what’s next with LLMs

Weekly Roundup – January 31, 2026

Embedding clinical intelligence to help close care gaps

Impact of Mobilization Facilitated by Wearable Device Enhanced Patient Monitoring/Electrophysiology Pod–Based Feedback on Postoperative Complications Following Colorectal Cancer Surgery: Randomized Controlled Trial

Tag: Trip Hofer

Brightside Health Raises Strategic Series C, Welcomes Trip Hofer to Board of Directors | Healthcare IT Today

Diverging trajectories of trust in healthcare and on-line information seeking: what’s next with LLMs

What impact has healow had on your organization and the patients’ experience?

Weekly Roundup – January 31, 2026

Embedding clinical intelligence to help close care gaps

Impact of Mobilization Facilitated by Wearable Device Enhanced Patient Monitoring/Electrophysiology Pod–Based Feedback on Postoperative Complications Following Colorectal Cancer Surgery: Randomized Controlled Trial

Meditech founder Neil Pappalardo dies at 83

The Landscape of Mobile Apps for Healthy Eating: Case Study for a Systematic Review and Quality Assessment

Decagon raises $250M for AI agents, triples valuation to $4.5B

Successful AI adoption requires meaningful change management

The Safe AI in Medicaid Alliance can help providers hone their tactics

MediFormatica

News Aggregator